Tb10.4 (M. Tuberculosis) Antikörper

Produktnummer ABIN361292

Produktdetails

Target: Tb10.4 (M. Tuberculosis)

Reaktivität: Mycobacterium tuberculosis

Wirt: Kaninchen

Klonalität: Polyklonal

Applikation: ELISA, Western Blotting (WB)

Verwendungszweck: Anti-Tb10.4 (M. tuberculosis) Purified

Spezifität: The rabbit polyclonal antibody to Tb10.4 reacts with Mycobacterium tuberculosis protein Tb10.4 (EsxH).

Aufreinigung: Purified by ligand affinity chromatography.

Reinheit: > 95 % (by SDS-PAGE)

Immunogen: Recombinant Tb10.4 protein produced in E. coli

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 mg/mL

Buffer: Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: Store at 2-8°C. Do not freeze.

Referenzen

Sergeeva, Romanovskaya-Romanko, Zabolotnyh, Pulkina, Vasilyev, Shurigina, Buzitskaya, Zabrodskaya, Fadeev, Vasin, Vinogradova, Stukova: "Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs." in: Vaccines, Vol. 9, Issue 4, (2021) (PubMed).

Leung-Theung-Long, Coupet, Gouanvic, Schmitt, Ray, Hoffmann, Schultz, Tyagi, Soni, Converse, Arias, Kleinpeter, Sansas, Mdluli, Vilaplana, Cardona, Nuermberger, Marchand, Silvestre, Inchauspé: "A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis." in: PLoS ONE, Vol. 13, Issue 5, pp. e0196815, (2018) (PubMed).

Antigendetails

Target: Tb10.4 (M. Tuberculosis)

Gen-ID: 886603